Share-based Payment Arrangement, Expense in USD of Perspective Therapeutics, Inc. from Q4 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Perspective Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q4 2011 to Q3 2025.
  • Perspective Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2.16M, a 10.5% increase year-over-year.
  • Perspective Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $8.72M, a 126% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.22M, a 66.1% increase from 2023.
  • Perspective Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.14M, a 306% increase from 2022.
  • Perspective Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $775K, a 101% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Perspective Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $8.72M $2.16M +$204K +10.5% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $8.51M $2.4M +$1.82M +309% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $6.7M $2.1M +$1.48M +237% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $5.22M $2.06M +$1.37M +197% 01 Oct 2024 31 Dec 2024 10-K/A 28 Mar 2025
Q3 2024 $3.85M $1.95M +$1.53M +367% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $2.32M $587K -$463K -44.1% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 $2.78M $622K -$360K -36.7% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 $3.14M $693K 01 Oct 2023 31 Dec 2023 10-K/A 28 Mar 2025
Q3 2023 $418K -$47K -10.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $1.05M +$896K +582% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $982K +$825K +525% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q3 2022 $956K $465K -$131K -22% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $1.09M $154K +$28K +22.2% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 $1.06M $157K +$63K +67% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $996K $180K +$99K +122% 01 Oct 2021 31 Dec 2021 10-Q 09 Feb 2022
Q3 2021 $897K $596K +$511K +601% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $386K $126K -$93K -42.5% 01 Apr 2021 30 Jun 2021 10-KT 01 May 2023
Q1 2021 $479K $94K +$3K +3.3% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 $476K $81K -$13K -13.8% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 $489K $85K -$6K -6.59% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $495K $219K +$68K +45% 01 Apr 2020 30 Jun 2020 10-KT 01 May 2023
Q1 2020 $427K $91K +$12K +15.2% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $415K $94K -$3K -3.09% 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021
Q3 2019 $418K $91K -$2K -2.15% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $420K $151K -$8K -5.03% 01 Apr 2019 30 Jun 2019 10-K 27 Sep 2021
Q1 2019 $428K $79K +$2K +2.6% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $426K $97K +$19K +24.4% 01 Oct 2018 31 Dec 2018 10-Q 12 Feb 2020
Q3 2018 $407K $93K +$3K +3.33% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $404K $159K -$51K -24.3% 01 Apr 2018 30 Jun 2018 10-K 25 Sep 2020
Q1 2018 $455K $77K +$37K +92.5% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 $418K $78K +$26K +50% 01 Oct 2017 31 Dec 2017 10-Q 13 Feb 2019
Q3 2017 $392K $90K +$20K +28.6% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $372K $210K +$149K +244% 01 Apr 2017 30 Jun 2017 10-K 27 Sep 2019
Q1 2017 $223K $40K -$126K -75.9% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018
Q4 2016 $349K $52K +$21K +67.7% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 $328K $70K +$38K +119% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 $290K $61K -$79.6K -56.6% 01 Apr 2016 30 Jun 2016 10-K 26 Sep 2018
Q1 2016 $370K $166K +$145K +674% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 $225K $31K +$9.55K +44.5% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017
Q3 2015 $216K $32K +$10.5K +49.2% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $205K $141K +$19.9K +16.5% 01 Apr 2015 30 Jun 2015 10-K 28 Sep 2017
Q1 2015 $185K $21.5K +$8.02K +59.7% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $177K $21.5K +$8.02K +59.7% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016
Q3 2014 $169K $21.5K -$16.9K -44.1% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $186K $121K +$97.8K +425% 01 Apr 2014 30 Jun 2014 10-K 09 Sep 2016
Q1 2014 $88.2K $13.4K -$14.1K -51.3% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 $102K $13.4K -$15.4K -53.4% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $118K $38.4K +$9.39K +32.4% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 $108K $23K 01 Apr 2013 30 Jun 2013 10-K 14 Sep 2015
Q1 2013 $27.6K -$5.61K -16.9% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $28.8K -$4.36K -13.1% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 $29K 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q1 2012 $33.2K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 $33.2K 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2013

Perspective Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.22M +$2.08M +66.1% 01 Jan 2024 31 Dec 2024 10-K/A 28 Mar 2025
2023 $3.14M +$2.37M +306% 01 Jan 2023 31 Dec 2023 10-K/A 28 Mar 2025
2022 $775K +$389K +101% 01 Jul 2021 30 Jun 2022 10-K 28 Mar 2024
2021 $386K -$109K -22% 01 Jul 2020 30 Jun 2021 10-KT 01 May 2023
2020 $495K +$75K +17.9% 01 Jul 2019 30 Jun 2020 10-KT 01 May 2023
2019 $420K +$16K +3.96% 01 Jul 2018 30 Jun 2019 10-K 27 Sep 2021
2018 $404K +$32K +8.6% 01 Jul 2017 30 Jun 2018 10-K 25 Sep 2020
2017 $372K +$82K +28.3% 01 Jul 2016 30 Jun 2017 10-K 27 Sep 2019
2016 $290K +$85K +41.5% 01 Jul 2015 30 Jun 2016 10-K 26 Sep 2018
2015 $205K +$19K +10.2% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2017
2014 $186K +$77.6K +71.7% 01 Jul 2013 30 Jun 2014 10-K 09 Sep 2016
2013 $108K -$65K -37.5% 01 Jul 2012 30 Jun 2013 10-K 14 Sep 2015
2012 $173K 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.